Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-15 Purchase |
2023-09-28 06:15 am |
OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director |
16,670 | $1.5 | $25,005 | 16,670 (Direct) |
View |
| 2022-05-19 Purchase |
2022-05-20 10:35 am |
OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman |
5,800,000 | $0.076 | $440,800 | 548,981,215 (Indirect) |
View |
| 2022-05-17 Purchase |
2022-05-18 11:37 am |
OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Non-Executive Chairman 10% Owner |
1,625,000 | $0.0595 | $96,688 | 544,806,215 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-23 Other |
2023-10-31 4:15 pm |
N/A N/A |
OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman |
569,539 | $1.5 | 9,747,442 (Indirect) |
View |
Ownership |
2022-05-16 5:53 pm |
N/A 2028-08-19 |
OKYO Pharma Ltd | OKYO | Shah Keeren Chief Financial Officer |
0 | $0 | 950,000 (Direct) |
View |
Ownership |
2022-05-16 5:52 pm |
N/A 2025-06-07 |
OKYO Pharma Ltd | OKYO | Simon Willy Jules Director |
0 | $0 | 2,000,000 (Direct) |
View |
Ownership |
2022-05-16 5:47 pm |
N/A 2028-08-19 |
OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director |
0 | $0 | 1,450,000 (Direct) |
View |
Ownership |
2022-05-16 5:44 pm |
N/A 2029-01-06 |
OKYO Pharma Ltd | OKYO | JACOB GARY S Chief Executive Officer |
0 | $0 | 53,000,000 (Direct) |
View |
Ownership |
2022-05-16 5:41 pm |
N/A N/A |
OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman 10% Owner |
0 | $0 | 543,181,215 (Indirect) |
View |
Ownership |
2022-05-16 5:37 pm |
N/A 2032-01-31 |
OKYO Pharma Ltd | OKYO | Denoyer Bernard Director |
0 | $0 | 1,000,000 (Direct) |
View |